COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04591210


Column Value
Trial registration number NCT04591210
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 31, 2023, 4 p.m.
Source : ClinicalTrials.gov

Peter Liu

Contact
Last imported at : May 31, 2023, 4 p.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-10-19

Recruitment status
Last imported at : May 31, 2023, 4 p.m.
Source : ClinicalTrials.gov

Not recruiting

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : June 16, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Sept. 29, 2022, 6 a.m.
Source : ClinicalTrials.gov

inclusion criteria: patient with covid-19 diagnosis with laboratory confirmation within the last 30 days and age 40 years old or greater if outpatient or age 18 years old or greater if inpatient (admitted to the hospital) at time of recruitment

Exclusion criteria
Last imported at : Sept. 29, 2022, 6 a.m.
Source : ClinicalTrials.gov

contraindication to arb or acei, including severe aortic stenosis and angioedema patients who are currently on active treatment with arb/acei known bilateral renal artery stenosis systolic bp ≤90 mmhg egfr<30 ml/min, if not receiving dialysis treatment k>5.5 mmol/l on screening laboratory testing recent history of dizziness, vertigo, related to hypotension or orthostatic hypotension, that can lead to contraindication to acei/arbs acute respiratory distress syndrome requiring invasive ventilation

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

7

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Ottawa Heart Institute Research Corporation

Inclusion age min
Last imported at : Sept. 29, 2022, 6 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : June 16, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Brazil;Canada;Mexico

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

1155

primary outcome
Last imported at : Sept. 29, 2022, 6 a.m.
Source : ClinicalTrials.gov

Death;Hospitalizations;ICU admission;Major Adverse Cardiac Events (MACE);Mechanical ventilation;Quality of life of study participants;Quality of life of study participants

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 973, "treatment_name": "Perindopril", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1061, "treatment_name": "Ramipril", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 460, "treatment_name": "Enalapril", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 248, "treatment_name": "Candesartan", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1349, "treatment_name": "Valsartan", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 744, "treatment_name": "Losartan", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]